{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T07:04:30Z","timestamp":1779519870150,"version":"3.53.1"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Antidepressants are commonly used psychiatric medications, many of them associated with significant toxicity in overdose. While established reference values are used in therapeutic monitoring of these drugs, there are less abundant reference data available in postmortem (PM) toxicology, especially concerning antidepressant metabolites. In this study, all such PM cases in 2016\u20132023 were retrieved from the Finnish national PM toxicology database in which an antidepressant drug and its metabolite were quantified concurrently in femoral venous blood, representing all causes of death (N\u2009=\u20093472). The results comprise the median concentrations of 11 antidepressants and their main metabolites, the parent drug plus metabolite sum concentrations, and the respective metabolite-to-parent drug ratio (MPR) values. The study revealed that the concentrations of antidepressants and their metabolites in PM blood generally increase in the following order according to the group studied: other cause of death than poisoning &amp;lt; implicated in fatal poisoning &amp;lt; principal finding in fatal antidepressant poisoning &amp;lt; single finding in fatal antidepressant poisoning. MPR was found to be a useful addition to concentration values in distinguishing acute poisoning death from other causes of death, showing lower MPR values in poisoning, and the results obtained in this study compared favorably with data previously published in the literature. The parent drug plus metabolite sum concentration did not provide significant additional information to parent drug only in PM diagnostics of poisoning.<\/jats:p>","DOI":"10.1093\/jat\/bkag012","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T12:29:04Z","timestamp":1770726544000},"source":"Crossref","is-referenced-by-count":0,"title":["Antidepressant metabolite concentrations and metabolite-to-parent drug ratios in postmortem femoral blood"],"prefix":"10.1093","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5721-2827","authenticated-orcid":false,"given":"Pirkko","family":"Kriikku","sequence":"first","affiliation":[{"name":"Forensic Toxicology Unit, Finnish Institute for Health and Welfare (THL) , Helsinki, FI-00271,","place":["Finland"]},{"name":"Department of Forensic Medicine, University of Helsinki , Helsinki, FI-00014,","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5790-1473","authenticated-orcid":false,"given":"Ilkka","family":"Ojanper\u00e4","sequence":"additional","affiliation":[{"name":"Forensic Toxicology Unit, Finnish Institute for Health and Welfare (THL) , Helsinki, FI-00271,","place":["Finland"]},{"name":"Department of Forensic Medicine, University of Helsinki , Helsinki, FI-00014,","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,2,15]]},"reference":[{"key":"2026052302060685500_bkag012-B1","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1177\/096032718300200301","article-title":"A collection of therapeutic, toxic and fatal blood drug concentrations in man","volume":"2","author":"Stead","year":"1983","journal-title":"Hum Toxicol"},{"key":"2026052302060685500_bkag012-B2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1520\/JFS14071J","article-title":"A compilation of fatal and control concentrations of drugs in postmortem femoral blood","volume":"42","author":"Druid","year":"1997","journal-title":"J Forensic Sci"},{"key":"2026052302060685500_bkag012-B3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/s0379-0738(01)00483-2","article-title":"Drug and chemical blood-level data 2001","volume":"122","author":"Winek","year":"2001","journal-title":"Forensic Sci Int"},{"key":"2026052302060685500_bkag012-B4","volume-title":"Disposition of Toxic Drugs and Chemicals in Man","author":"Baselt","year":"2017","edition":"11th edn"},{"key":"2026052302060685500_bkag012-B5","doi-asserted-by":"publisher","first-page":"e1480","DOI":"10.1002\/wfs2.1480","article-title":"Post-mortem redistribution of drugs and other factors affecting interpretation: A review","volume":"5","author":"Drummer","year":"2023","journal-title":"WIRES Forensic Sci"},{"key":"2026052302060685500_bkag012-B6","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/dta.1507","article-title":"Drug concentrations in post-mortem femoral blood compared with therapeutic concentrations in plasma","volume":"6","author":"Launiainen","year":"2014","journal-title":"Drug Test Anal"},{"key":"2026052302060685500_bkag012-B7","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/BF03161207","article-title":"Suicidal antidepressant overdoses: a comparative analysis by antidepressant type","volume":"4","author":"White","year":"2008","journal-title":"J Med Toxicol"},{"key":"2026052302060685500_bkag012-B8","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1192\/bjp.bp.109.070219","article-title":"Toxicity of antidepressants: rates of suicide relative to prescribing and non-fatal overdose","volume":"196","author":"Hawton","year":"2010","journal-title":"Br J Psychiatry"},{"key":"2026052302060685500_bkag012-B9","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s00414-016-1358-8","article-title":"Fatal toxicity index of medicinal drugs based on a comprehensive toxicology database","volume":"130","author":"Ojanper\u00e4","year":"2016","journal-title":"Int J Legal Med"},{"key":"2026052302060685500_bkag012-B10","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1176\/appi.ajp.2016.16050523","article-title":"Morbidity and mortality associated with medications used in the treatment of depression: An analysis of cases reported to U.S. Poison Control Centers, 2000-2014","volume":"174","author":"Nelson","year":"2017","journal-title":"Am J Psychiatry"},{"key":"2026052302060685500_bkag012-B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.genhosppsych.2024.05.002","article-title":"Three safety indices for the fourteen most prescribed antidepressants in the US, 2013-2020","volume":"90","author":"Poliacoff","year":"2024","journal-title":"Gen Hosp Psychiatry"},{"key":"2026052302060685500_bkag012-B12","doi-asserted-by":"publisher","first-page":"20451253241243297","DOI":"10.1177\/20451253241243297","article-title":"The cardiovascular safety of tricyclic antidepressants in overdose and in clinical use","volume":"14","author":"Taylor","year":"2024","journal-title":"Ther Adv Psychopharmacol"},{"key":"2026052302060685500_bkag012-B13","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1093\/jat\/bkad044","article-title":"Fatal concentrations of antidepressant and antipsychotic drugs in postmortem femoral blood","volume":"47","author":"Kriikku","year":"2023","journal-title":"J Anal Toxicol"},{"key":"2026052302060685500_bkag012-B14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1055\/s-0043-116492","article-title":"Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: Update 2017","volume":"51","author":"Hiemke","year":"2018","journal-title":"Pharmacopsychiatry"},{"key":"2026052302060685500_bkag012-B15","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.forsciint.2012.07.011","article-title":"Comparison of fatal poisonings by prescription opioids","volume":"222","author":"H\u00e4kkinen","year":"2012","journal-title":"Forensic Sci Int"},{"key":"2026052302060685500_bkag012-B16","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1093\/jat\/13.4.197","article-title":"Postmortem tricyclic antidepressant concentrations: assessing cause of death using parent drug to metabolite \u00adratio","volume":"13","author":"Apple","year":"1989","journal-title":"J Anal Toxicol"},{"key":"2026052302060685500_bkag012-B17","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1093\/jat\/31.5.254","article-title":"Reference concentrations of antidepressants. A compilation of postmortem and therapeutic levels","volume":"31","author":"Reis","year":"2007","journal-title":"J Anal Toxicol"},{"key":"2026052302060685500_bkag012-B18","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1002\/dta.2655","article-title":"Summary statistics for drug concentrations in post-mortem femoral blood representing all causes of death","volume":"11","author":"Ketola","year":"2019","journal-title":"Drug Test Anal"},{"key":"2026052302060685500_bkag012-B19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/dta.1818","article-title":"Patterns of drug abuse among drug users with regular and irregular attendance for treatment as detected by comprehensive UHPLC-HR-TOF-MS","volume":"8","author":"Sundstr\u00f6m","year":"2016","journal-title":"Drug Test Anal"},{"key":"2026052302060685500_bkag012-B20","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.forsciint.2016.08.031","article-title":"Concurrent estimation of metabolite concentrations along with parent drug quantification in post-mortem blood","volume":"267","author":"Viinam\u00e4ki","year":"2016","journal-title":"Forensic Sci Int"},{"key":"2026052302060685500_bkag012-B21","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00414-010-0461-5","article-title":"Fatal venlafaxine poisonings are associated with a high prevalence of drug interactions","volume":"125","author":"Launiainen","year":"2011","journal-title":"Int J Legal Med"},{"key":"2026052302060685500_bkag012-B22","volume-title":"StatPearls [Internet]","author":"Moraczewski","year":"2025"},{"key":"2026052302060685500_bkag012-B23","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1093\/jat\/bkaa107","article-title":"Postmortem drug redistribution: A compilation of postmortem\/antemortem drug concentration ratios","volume":"45","author":"Mantinieks","year":"2021","journal-title":"J Anal Toxicol"},{"key":"2026052302060685500_bkag012-B24","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1093\/jat\/bky058","article-title":"Degradation of bupropion: Implications for interpretation of postmortem case data","volume":"42","author":"Bishop-Freeman","year":"2018","journal-title":"J Anal Toxicol"},{"key":"2026052302060685500_bkag012-B25","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1002\/med.21671","article-title":"New-generation, non-SSRI antidepressants: Drug-drug interactions and therapeutic drug monitoring. Part 2: NaSSAs, NRIs, SNDRIs, MASSAs, NDRIs, and others","volume":"40","author":"Protti","year":"2020","journal-title":"Med Res Rev"},{"key":"2026052302060685500_bkag012-B26","doi-asserted-by":"publisher","first-page":"110292","DOI":"10.1016\/j.forsciint.2020.110292","article-title":"The importance of sample size with regard to the robustness of postmortem reference values","volume":"311","author":"S\u00f6derberg","year":"2020","journal-title":"Forensic Sci Int"},{"key":"2026052302060685500_bkag012-B27","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/jat\/bkae052","article-title":"Difficulties associated with the interpretation of postmortem toxicology","volume":"48","author":"Stephenson","year":"2024","journal-title":"J Anal Toxicol"},{"key":"2026052302060685500_bkag012-B28","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.forsciint.2014.01.005","article-title":"Sedative and hypnotic drugs\u2014fatal and non-fatal reference blood concentrations","volume":"236","author":"J\u00f6nsson","year":"2014","journal-title":"Forensic Sci Int"}],"container-title":["Journal of Analytical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jat\/advance-article-pdf\/doi\/10.1093\/jat\/bkag012\/66920563\/bkag012.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jat\/article-pdf\/50\/4\/bkag012\/66920563\/bkag012.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jat\/article-pdf\/50\/4\/bkag012\/66920563\/bkag012.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T06:06:16Z","timestamp":1779516376000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jat\/article\/doi\/10.1093\/jat\/bkag012\/8487192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,15]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,5,23]]}},"URL":"https:\/\/doi.org\/10.1093\/jat\/bkag012","relation":{},"ISSN":["0146-4760","1945-2403"],"issn-type":[{"value":"0146-4760","type":"print"},{"value":"1945-2403","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2026,2,15]]},"article-number":"bkag012"}}